It has also been postulated that any observed association may be due to the use of tamoxifen for the prevention and treatment of breast cancer rather than a consequence of a BRCA1 or BRCA2 pathogenic variant per se [13,14]. This evidence concerns the gene BRCA2 and breast carcinoma.